Read article—Richard Kaufman and Nancy Dunbar, professors of pathology and laboratory medicine, are quoted in coverage of a Dartmouth-led study finding that alpha-gal syndrome can increase the risk of severe allergic reactions to certain blood transfusions, which could potentially change transfusion practices in regions where the tick-borne disease is more common. “The changing climate and ensuing greater proliferation of ticks is leading to illnesses and symptoms we had not seen before, and we continue to learn about them in real time,” Dunbar said.

Read article—Kathleen Clem, a professor of emergency medicine, is quoted in an opinion piece about cannabinoid hyperemesis syndrome, which  can cause severe vomiting and why heat may temporarily relieve symptoms. “Every time that someone who has CHS uses a drug with cannabis in it, they can develop these same symptoms again,” Clem said.

Watch Video—Nicholas Jacobson, an associate professor ofbiomedical data science and psychiatry, and the Therabot platform developed at Dartmouth are featured in a story about  young people using AI therapy chatbots. “I think one of the things that folks often don’t consider when they think about what our current care system is that most folks are not accessing a human already,” Jacobson said.

Read article—Amber Barnato, a professor of medicine, testified Monday at an FDA public hearing on psychedelic therapies, pointing to evidence that psilocybin-assisted treatment can produce durable reductions in depression, anxiety and demoralization among patients facing life-threatening illness, but that more research is required.

Read article—Shane Chapman, a professor of dermatology, is featured discussing FDA approval of a nonsurgical photodynamic therapy option for superficial basal cell carcinoma. “I see this as a meaningful expansion in the use of this treatment,” Chapman said.

Read article—Features a study led by Lynn Fiellin, a professor of biomedical data science and medicine, and postdoctoral research fellow Caroline Barry showing that PlaySmart, a digital behavioral health game developed in the Fiellin lab, reduced depressive symptoms among teens and improved attitudes toward seeking mental health care. “The key takeaway for clinicians and schools is that prevention does not have to wait until an adolescent is in crisis,” Barry said. “Digital tools like PlaySmart may provide another way to engage young people earlier and in a format that feels familiar and interactive.”

Read article—In an opinion piece, Miriam Voran, an assistant professor of psychology, offers guidance for parents on helping children navigate political instability, emphasizing age-appropriate conversations, emotional regulation, and independent thinking. “Stand for reality, but don’t rush your children out of childhood. Remember that civic education fits the goal of keeping up with your child’s maturing interests,” Voran writes. “Educate your children about the broader world.”

Read article—Angelo Volandes, senior associate dean for clinical and translational research at Geisel, and Nathan Goldstein, a professor of geriatrics, are featured in a story about a new federally funded Dartmouth Health and Geisel research program to study healthcare access for older adults in rural communities.

Read article—Features an international study led by Dartmouth researchers at Geisel and Dartmouth Health identifying a potential transfusion risk for patients with alpha-gal syndrome, particularly type O patients receiving B or AB plasma or platelets.

Read article—A report authored by Jared Rhodes, a professor of health policy, ranks New Hampshire sixth nationally for health care freedom. The report credits reforms to professional licensing and pharmacy scope of practice, along with adoption of Right to Try legislation, with helping the state rise in the rankings.